Intellia Therapeutics
| Use attributes for filter ! | |
| Stock price | NTLA |
|---|---|
| Disclaimer | |
| Headquarters | Cambridge |
| Massachusetts | |
| United States | |
| Founded | 2014 |
| Executives | John Leonard |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046061 |
About Intellia Therapeutics
Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.
